[1] 石枫.乳腺癌患者腋窝level Ⅲ组淋巴结研究进展[J].菏泽医学专科学校学报,2010,22(1):90-92.
[2] Dillon MF,Advani V,Masterson C,et al.The value of level Ⅲ clearance in patients with axillary and sentinel node positive breast cancer[J].Ann Surg,2009,249(5):834-839.
[3] 甫拉提·吾瓦力汗,李涌涛,欧江华,等.乳腺癌Kodama法改良根治术的临床应用研究[J].中国肿瘤临床,2011,38(18):1172-1174.
[4] 邹汉青,杭剑萍,徐韶华.Kodama改良根治术在老年乳腺癌中的应用观察[J].中国老年学杂志,2009,29(8):1031-1032.
[5] Keskek M,Balas S,Gokoz A,et al.Re-evaluation of axillary skip metastases in the era of sentinel lymph node biopsy in breast cancer[J].Surg Today,2006,36(12):1047-1052.
[6] Yildirim E,Berberoglu U.Lymph node ratio is more valuable than level Ⅲ involvement for prediction of outcome in node-positive breast carcinoma patients[J].World J Surg,2007,31(2):276-289.
[7] 徐有富,苏新良.乳腺癌第Ⅲ组淋巴结转移的多因素分析[J].中国肿瘤,2011,20(6):466-468.
[8] 崔进军,宗林,陈松,等.乳腺癌前哨淋巴结阳性患者行Level Ⅲ组淋巴结清扫的临床探讨[J].右江医学,2012,40(5):667-668.
[9] Susanne H,Estourgie MD,Omgo E,et al.Lymphatic drainage patterns from the breast[J].Ann Surg,2004,2336(9):232-237.
[10] 曾健,石枫,陆云飞,等.乳腺癌腋窝level Ⅲ组淋巴结微转移的检测和临床意义[J].中国肿瘤临床,2009,36(9):481-485.
[11] 马祥君,何湘萍,汪洁,等.早期乳腺癌腋窝亚LevelⅡ淋巴结清扫的初步研究[J].现代肿瘤医学,2011,19(6):1139-1141.